Flexible Defenses Roundtable Meeting: Promoting the Strategic Innovation of Medical Countermeasures
- 1 September 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
- Vol. 5 (3) , 271-277
- https://doi.org/10.1089/bsp.2007.0039
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Biomedical Advanced Research and Development Authority (BARDA) RoundtableBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2007
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006
- Bioterrorism — Preparing to Fight the Next WarNew England Journal of Medicine, 2006
- Taking the Measure of Countermeasures: Leaders' Views on the Nation's Capacity to Develop Biodefense CountermeasuresBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2004
- Biodefense R&D: Anticipating Future Threats, Establishing a Strategic EnvironmentBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003